306 related articles for article (PubMed ID: 24429319)
1. Performance of the MTBDRsl assay in Georgia.
Tukvadze N; Bablishvili N; Apsindzelashvili R; Blumberg HM; Kempker RR
Int J Tuberc Lung Dis; 2014 Feb; 18(2):233-9. PubMed ID: 24429319
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
[TBL] [Abstract][Full Text] [Related]
3. Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
Rahman SMM; Nasrin R; Rahman A; Ahmed S; Khatun R; Uddin MKM; Rahman MM; Banu S
PLoS One; 2021; 16(12):e0261329. PubMed ID: 34914803
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
Int J Tuberc Lung Dis; 2012 Jan; 16(1):104-9. PubMed ID: 22236854
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of MTBDR
Chandak RJ; Malhotra B; Bhargava S; Goel SK; Verma D; Tiwari J
Int J Tuberc Lung Dis; 2019 Dec; 23(12):1257-1262. PubMed ID: 31931908
[No Abstract] [Full Text] [Related]
7. Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.
Barnard M; Warren R; Gey Van Pittius N; van Helden P; Bosman M; Streicher E; Coetzee G; O'Brien R
Am J Respir Crit Care Med; 2012 Dec; 186(12):1298-305. PubMed ID: 23087027
[TBL] [Abstract][Full Text] [Related]
8. Impact of
Bablishvili N; Tukvadze N; Shashkina E; Mathema B; Gandhi NR; Blumberg HM; Kempker RR
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630205
[TBL] [Abstract][Full Text] [Related]
9. Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay.
Trollip AP; Moore D; Coronel J; Caviedes L; Klages S; Victor T; Romancenco E; Crudu V; Ajbani K; Vineet VP; Rodrigues C; Jackson RL; Eisenach K; Garfein RS; Rodwell TC; Desmond E; Groessl EJ; Ganiats TG; Catanzaro A
Int J Tuberc Lung Dis; 2014 Feb; 18(2):227-32. PubMed ID: 24429318
[TBL] [Abstract][Full Text] [Related]
10. Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.
Singh K; Kumari R; Gupta S; Tripathi R; Srivastava A; Shakya V; Gupta A; Anupurba S
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):56. PubMed ID: 34446022
[TBL] [Abstract][Full Text] [Related]
11. Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
Gao Y; Zhang Z; Deng J; Mansjö M; Ning Z; Li Y; Li X; Hu Y; Hoffner S; Xu B
J Infect; 2018 Oct; 77(4):328-334. PubMed ID: 29969597
[TBL] [Abstract][Full Text] [Related]
12. Performance of the GenoType MTBDRsl assay for the detection second-line anti-tuberculosis drug resistance.
Lee YS; Lee BY; Jo KW; Shim TS
J Infect Chemother; 2017 Dec; 23(12):820-825. PubMed ID: 29066216
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
[TBL] [Abstract][Full Text] [Related]
14. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant
Varghese B; Al-Hajoj S
Am J Trop Med Hyg; 2017 May; 96(5):1066-1070. PubMed ID: 28500800
[TBL] [Abstract][Full Text] [Related]
15. Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
Ramos E; Fissette K; de Rijk P; Palomino JC; Martin A
Int J Tuberc Lung Dis; 2012 Jan; 16(1):110-3. PubMed ID: 22236855
[TBL] [Abstract][Full Text] [Related]
16. Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China.
Shi W; Davies Forsman L; Hu Y; Zheng X; Gao Y; Li X; Jiang W; Bruchfeld J; Diwan VK; Hoffner S; Xu B
Int J Infect Dis; 2020 Jul; 96():390-397. PubMed ID: 32353546
[TBL] [Abstract][Full Text] [Related]
17. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
18. Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China.
Zeng X; Jing W; Zhang Y; Duan H; Huang H; Chu N
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):112-117. PubMed ID: 27345127
[TBL] [Abstract][Full Text] [Related]
19. Underestimation of the resistance of Mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test.
Jin J; Shen Y; Fan X; Diao N; Wang F; Wang S; Weng X; Zhang W
J Mol Diagn; 2013 Jan; 15(1):44-50. PubMed ID: 23159109
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the GenoType(®) MTBDRplus line probe assay on sputum-positive samples in routine settings in China.
Chen C; Kong W; Zhu L; Zhou Y; Peng H; Shao Y; Song H; Liu Q; Li G; Shi J; Zhong C; Zhu L; Ding X; Yu H; Yang H; Lu W
Int J Tuberc Lung Dis; 2014 Sep; 18(9):1034-9. PubMed ID: 25189549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
